RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0045-1809669
Autologous Nanofragmented Lipoinjection (Nanofat) for the Treatment of Complex Anorectal Fistula Associated with Crohn's Disease
Funding No fundings were required for this manuscript.
Abstract
The management of complex anorectal fistulas associated with Crohn's Disease (CD) remains a significant clinical challenge, with current treatments achieving limited success in long-term remission. This article explores the application of autologous nanofragmented lipoinjection (Nanofat) for the treatment of Perianal Fistulizing Crohn's Disease (PFCD). Nanofat, derived from adipose tissue and containing mesenchymal stem cells, offers the potential for tissue regeneration and immune modulation in the inflammatory environment of perianal CD. A patient with a chronic fistula, previously treated with Seton and maintained biologic therapy, underwent liposuction and nanofragmentation of adipose tissue. The resulting Nanofat was injected into the fistula tract following surgical debridement. The patient demonstrated complete healing with no recurrence of symptoms after six months, showcasing the efficacy of this technique. This autologous approach is low-cost, minimally invasive, and reproducible, with promising clinical outcomes. The addition of nanofragmented fat enhances tissue penetration and fat survival compared with traditional Microfat, increasing the chances of successful fistula repair. Further controlled studies comparing Nanofat with other established fistula repair methods are warranted to assess its long-term efficacy and standardize treatment protocols.
Keywords
Perianal Crohn's disease - Crohn's disease - mesenchymal stem cell - cell regenerative therapy - microfragmented adipose tissue - nanofatPublikationsverlauf
Eingereicht: 02. April 2025
Angenommen: 22. Mai 2025
Artikel online veröffentlicht:
26. Juni 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Alexandre Lopes de Carvalho, Lina Maria Goes de Codes, Alana Francisca Machado Melo, Flávia de Castro Ribeiro Fidelis, Bruna Fernandes Barreiro de Araújo, Fabio Pereira Soares de Araújo, Tiago Pereira de Castro, José Valber Lima Meneses. Autologous Nanofragmented Lipoinjection (Nanofat) for the Treatment of Complex Anorectal Fistula Associated with Crohn's Disease. Journal of Coloproctology 2025; 45: s00451809669.
DOI: 10.1055/s-0045-1809669
-
References
- 1 Quaresma AB, Damiao AOMC, Coy CSR. et al. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study. Lancet Reg Health Am 2022; 13: 100298
- 2 Ng SC, Shi HY, Hamidi N. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017; 390 (10114): 2769-2778
- 3 Schwartz DA, Loftus Jr EV, Tremaine WJ. et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122 (04) 875-880
- 4 Kotze PG, Albuquerque IC, da Luz Moreira A, Tonini WB, Olandoski M, Coy CS. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study. Arq Gastroenterol 2014; 51 (04) 284-289 http://www.scielo.br/j/ag/a/
- 5 Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg 2013; 132 (04) 1017-1026
- 6 Tonnard P, Verpaele A, Bensimon R. Eds Centrofacial Rejuvenation. Vol III. Stuttgart, Germany: Thieme; 2013. . Disponível em: https://www.thieme.com
- 7 Dige A, Hougaard HT, Agnholt J. et al. Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn's disease. Gastroenterology 2019; 156 (08) 2208-2216.e1
- 8 Dalby HR, Dige A, Pedersen BG. et al. Efficacy of injection of freshly collected autologous adipose tissue into complex cryptoglandular anal fistulas. Dis Colon Rectum 2023; 66 (03) 443-450
- 9 Kenkel JM, Stephan PJ. Neligan Cirurgia Plástica Vol 2 Estética. 3ª ed.. Rio de Janeiro, Brazil: Editora Elsevier; 2015. . Disponível em: https://www.elsevier.com
- 10 Wu S, Coombs DM, Gurunian R. Liposuction: Concepts, safety, and techniques in body-contouring surgery. Cleve Clin J Med 2020; 87 (06) 367-375
- 11 Matarasso A, Hutchinson OH. Liposuction. JAMA 2001; 285 (03) 266-268
- 12 Georgiev-Hristov T, Guadalajara H, Herreros MD. et al. A step-by-step surgical protocol for the treatment of perianal fistula with adipose-derived mesenchymal stem cells. J Gastrointest Surg 2018; 22 (11) 2003-2012
- 13 Tozer PJ, Lung P, Lobo AJ. et al. on behalf of ENiGMA Collaboration. Review article: pathogenesis of Crohn's perianal fistula—understanding factors impacting on success and failure of treatment strategies. Aliment Pharmacol Ther 2018; 1: 1-10
- 14 Abcarian H. Anal Fistula: Principles and Management. Springer Science & Business Media; 2013. . Disponível em: https://link.springer.com
- 15 Serrero M, Grimaud F, Philandrianos C, Visée C, Sabatier F, Grimaud J-C. Long-term safety and efficacy of local microinjection combining autologous microfat and adipose-derived stromal vascular fraction for the treatment of refractory perianal fistula in Crohn's disease. Gastroenterology 2019; 156 (08) 2335-2337.e2